• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DC-NK细胞相互作用作为一种不依赖CD4+ T细胞的新型抗肿瘤CTL诱导途径。

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

作者信息

Adam Christian, King Susan, Allgeier Thomas, Braumüller Heidi, Lüking Carolin, Mysliwietz Josef, Kriegeskorte Anja, Busch Dirk H, Röcken Martin, Mocikat Ralph

机构信息

GSF-Institut für Molekulare Immunologie, Marchioninistr. 25, D-81377 München, Germany.

出版信息

Blood. 2005 Jul 1;106(1):338-44. doi: 10.1182/blood-2004-09-3775. Epub 2005 Mar 15.

DOI:10.1182/blood-2004-09-3775
PMID:15769894
Abstract

It is generally accepted that priming of antitumor CD8+ cytotoxic T lymphocytes (CTLs) needs help that can be provided by CD4+ T cells. We show that interactions between dendritic cells (DCs) and natural killer (NK) cells can bypass the T helper arm in CTL induction. Bone marrow-derived DCs caused rejection of the A20 lymphoma and induced tumor-specific long-term memory, although they were not loaded with tumor-derived antigen. Experiments using CD40(-) knock-out mice and cell depletion showed that this effect did not require CD4+ cells. Both primary rejection and long-term CTL memory were the result of NK cell activation by DCs. NK cytotoxicity, which was necessary for primary rejection, was dependent on expression of natural killer group 2 D (NKG2D) ligands on tumor cells. Blocking of these ligands using NKG2D tetramers abrogated tumor killing in vitro and in vivo. The long-term response was due to CTLs directed against antigen(s) expressed on A20 and in vitro-differentiated DCs. The mechanism leading to CD4+ helper cell-independent CTL responses was elucidated as a cascade that was initiated by NK cell activation. This pathway was dependent on inter-feron-gamma expression and involved priming endogenous DCs for interleukin-12 production. Our data suggest a novel pathway linking innate and adaptive immunity.

摘要

普遍认为,抗肿瘤CD8+细胞毒性T淋巴细胞(CTL)的启动需要CD4+ T细胞提供的帮助。我们发现,树突状细胞(DC)与自然杀伤(NK)细胞之间的相互作用可以在CTL诱导过程中绕过T辅助细胞环节。骨髓来源的DC能够引发A20淋巴瘤的排斥反应并诱导肿瘤特异性长期记忆,尽管它们并未负载肿瘤衍生抗原。使用CD40基因敲除小鼠和细胞清除实验表明,这种效应并不需要CD4+细胞。初次排斥反应和长期CTL记忆均是DC激活NK细胞的结果。初次排斥反应所必需的NK细胞毒性取决于肿瘤细胞上自然杀伤细胞组2 D(NKG2D)配体的表达。使用NKG2D四聚体阻断这些配体可在体外和体内消除肿瘤杀伤作用。长期反应是由于CTL针对A20和体外分化DC上表达的抗原。导致不依赖CD4+辅助细胞的CTL反应的机制被阐明为一个由NK细胞激活引发的级联反应。该途径依赖于γ干扰素的表达,并涉及启动内源性DC产生白细胞介素-12。我们的数据提示了一条连接固有免疫和适应性免疫的新途径。

相似文献

1
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.DC-NK细胞相互作用作为一种不依赖CD4+ T细胞的新型抗肿瘤CTL诱导途径。
Blood. 2005 Jul 1;106(1):338-44. doi: 10.1182/blood-2004-09-3775. Epub 2005 Mar 15.
2
CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.不依赖CD40的自然杀伤细胞辅助作用可促进树突状细胞疫苗诱导的针对内源性B细胞淋巴瘤的T细胞免疫。
Int J Cancer. 2014 Dec 15;135(12):2825-33. doi: 10.1002/ijc.28932. Epub 2014 May 8.
3
Dendritic cell-induced activation of adaptive and innate antitumor immunity.树突状细胞诱导的适应性和先天性抗肿瘤免疫激活。
J Immunol. 2003 Dec 1;171(11):5842-52. doi: 10.4049/jimmunol.171.11.5842.
4
Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.在较高的 CD8(+) T 细胞前体频率下,CD4(+) T 细胞信号对效应细胞毒性 T 淋巴细胞 (CTL) 启动和功能性记忆 CTL 发育的差异需求。
Immunology. 2013 Apr;138(4):298-306. doi: 10.1111/imm.12033.
5
Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.树突状细胞-肿瘤共培养疫苗可通过自然杀伤细胞(NK)和细胞毒性T淋巴细胞(CTL)的相互作用诱导抗肿瘤免疫。
Int Immunopharmacol. 2001 Nov;1(12):2117-29. doi: 10.1016/s1567-5769(01)00137-0.
6
Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.利用树突状细胞和自然杀伤细胞,通过白细胞介素18快速产生强效且肿瘤特异性的细胞毒性T淋巴细胞。
Cancer Res. 2000 Sep 1;60(17):4838-44.
7
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.细胞因子基因共转导对使用表达肿瘤相关抗原的基因修饰树突状细胞进行癌症疫苗治疗的增强作用。
Int J Oncol. 2006 Apr;28(4):947-53.
8
HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8 T and NK cells: a novel therapeutic tumour vaccine.HLA-A2.1 限制性 ECM1 衍生表位 LA 通过 DC 交叉激活启动 CD8 T 和 NK 细胞:一种新型治疗性肿瘤疫苗。
J Hematol Oncol. 2021 Apr 28;14(1):71. doi: 10.1186/s13045-021-01081-7.
9
Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.基因改造的树突状细胞通过一条独立于CD40L和白细胞介素12的途径启动自身反应性T细胞:对癌症疫苗的启示。
Cancer Res. 2000 Jun 15;60(12):3247-53.
10
Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.树突状细胞疫苗抑制肿瘤转移需要活化的自然杀伤细胞介导的免疫。
Exp Mol Med. 2004 Oct 31;36(5):428-43. doi: 10.1038/emm.2004.55.

引用本文的文献

1
Targeting immune microenvironment in cervical cancer: current research and advances.宫颈癌免疫微环境的靶向治疗:当前研究与进展
J Transl Med. 2025 Aug 8;23(1):888. doi: 10.1186/s12967-025-06896-3.
2
Exercise-mobilized donor lymphocyte infusions enhanced with cytokine stimulation for the prevention and treatment of leukemic relapse after allogeneic hematopoietic cell transplantation.通过细胞因子刺激增强运动动员的供体淋巴细胞输注,用于预防和治疗异基因造血细胞移植后的白血病复发。
Front Immunol. 2025 Jun 12;16:1563972. doi: 10.3389/fimmu.2025.1563972. eCollection 2025.
3
Combination Treatment of Rituximab and Therapeutic Vaccines Affords Superior Tumor Suppression and Relapse Prevention for Non-Hodgkin Lymphoma.
利妥昔单抗与治疗性疫苗联合治疗为非霍奇金淋巴瘤提供了卓越的肿瘤抑制和复发预防效果。
Adv Mater. 2025 Jul;37(26):e2502372. doi: 10.1002/adma.202502372. Epub 2025 Apr 11.
4
Germline natural killer cell receptors modulating the T cell response.胚系自然杀伤细胞受体调节 T 细胞反应。
Front Immunol. 2024 Nov 4;15:1477991. doi: 10.3389/fimmu.2024.1477991. eCollection 2024.
5
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.自然杀伤细胞功能、信号转导、分子机制及临床应用的综合概述。
Signal Transduct Target Ther. 2024 Nov 8;9(1):302. doi: 10.1038/s41392-024-02005-w.
6
The Multifaceted Roles of NK Cells in the Context of Murine Cytomegalovirus and Lymphocytic Choriomeningitis Virus Infections.自然杀伤细胞在小鼠巨细胞病毒和淋巴细胞性脉络丛脑膜炎病毒感染背景下的多方面作用
Immune Netw. 2024 Jun 27;24(4):e29. doi: 10.4110/in.2024.24.e29. eCollection 2024 Aug.
7
The basic biology of NK cells and its application in tumor immunotherapy.自然杀伤细胞的基础生物学及其在肿瘤免疫治疗中的应用。
Front Immunol. 2024 Aug 16;15:1420205. doi: 10.3389/fimmu.2024.1420205. eCollection 2024.
8
Natural Killer cells at the frontline in the fight against cancer.自然杀伤细胞在抗击癌症的第一线。
Cell Death Dis. 2024 Aug 23;15(8):614. doi: 10.1038/s41419-024-06976-0.
9
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity.肿瘤进入体内后自然杀伤细胞的快速功能障碍限制了抗肿瘤免疫。
Nat Commun. 2024 Jan 24;15(1):683. doi: 10.1038/s41467-024-44789-z.
10
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential.自然杀伤细胞在癌症中的作用:功能障碍的机制与治疗潜能。
Int J Mol Sci. 2023 May 30;24(11):9521. doi: 10.3390/ijms24119521.